Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2024 Poal.co

116

Moderna is dialing back its plans for new vaccines, shelving several key projects as it grapples with a sharp slowdown in COVID shot sales. . .

Archive (archive.today) (Archive is incredibly slow today, still processing as I post)

>Moderna is dialing back its plans for new vaccines, shelving several key projects as it grapples with a sharp slowdown in COVID shot sales. . . [Archive](https://archive.today/HKGdC) (Archive is incredibly slow today, still processing as I post)
You are currently inside a comment thread.
Click here to see all the comments (3).
[–] • 4 pts (edited )

Stunning. Imagine a startup producing a fatal product and later their revenue collapses. Where are we?

The company came to the world's rescue during the pandemic

LOL

It expects 10 to win approval in the next three years, including a combination flu-COVID vaccine

LOL

Moderna's stock fell over 12% Thursday, having tumbled from its all-time high above $449 in September 2021 — a wipeout of nearly $170 billion of market value over the three years.

Not nearly enough.

Moderna's technology is promising

Umm.. based on its spectacular failure?